June 2017:
        Paradox Pharmaceuticals selected to present at           the Kansas City Animal Health Investment Forum         in August.


May 2017:
        AD 198 study published in Journal of Cellular               Biochemistry.

February 2016:
        AD 198 study published in Leukemia Research.

Products:

​​Innovative therapies
                         Superior outcomes

Latest News:

Redefining anthracyclines to create clinically effective, non-cardiotoxic agents for treating cancer in companion animals.